Davletgildeeva A, Kuznetsov N
Biomolecules. 2024; 14(9).
PMID: 39334883
PMC: 11430729.
DOI: 10.3390/biom14091117.
Shen Y, Thng D, Wong A, Toh T
Exp Hematol Oncol. 2024; 13(1):40.
PMID: 38615034
PMC: 11015656.
DOI: 10.1186/s40164-024-00512-8.
Ghasemi B, Ahmadi J, Zaker F, Tabatabaei T, Kiani-Zadeh M, Kazemi A
Indian J Hematol Blood Transfus. 2024; 40(1):52-60.
PMID: 38312186
PMC: 10831019.
DOI: 10.1007/s12288-023-01673-y.
Xing C, Zhu S, Yan W, Zhu H, Huang Z, Zhao Y
Heliyon. 2023; 9(11):e22209.
PMID: 38045198
PMC: 10689887.
DOI: 10.1016/j.heliyon.2023.e22209.
Isachesku E, Braicu C, Pirlog R, Kocijancic A, Busuioc C, Pruteanu L
Int J Mol Sci. 2023; 24(22).
PMID: 38003512
PMC: 10671451.
DOI: 10.3390/ijms242216320.
Deciphering glioma epitranscriptome: focus on RNA modifications.
Piperi C, Markouli M, Gargalionis A, Papavassiliou K, Papavassiliou A
Oncogene. 2023; 42(28):2197-2206.
PMID: 37322070
DOI: 10.1038/s41388-023-02746-y.
Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics.
Tuzesi A, Hallal S, Satgunaseelan L, Buckland M, Alexander K
Cancers (Basel). 2023; 15(4).
PMID: 36831575
PMC: 9954771.
DOI: 10.3390/cancers15041232.
Translational Regulation by eIFs and RNA Modifications in Cancer.
Zhang L, Zhang Y, Zhang S, Qiu L, Zhang Y, Zhou Y
Genes (Basel). 2022; 13(11).
PMID: 36360287
PMC: 9690228.
DOI: 10.3390/genes13112050.
Ascorbate content of clinical glioma tissues is related to tumour grade and to global levels of 5-hydroxymethyl cytosine.
Crake R, Burgess E, Wiggins G, Magon N, Das A, Vissers M
Sci Rep. 2022; 12(1):14845.
PMID: 36050369
PMC: 9436949.
DOI: 10.1038/s41598-022-19032-8.
Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma.
Pan Q, Yi C, Zhang Y
Front Oncol. 2022; 12:884377.
PMID: 35686101
PMC: 9172585.
DOI: 10.3389/fonc.2022.884377.
M5C-Related lncRNA Predicts Lung Adenocarcinoma and Tumor Microenvironment Remodeling: Computational Biology and Basic Science.
Bai M, Sun C
Front Cell Dev Biol. 2022; 10:885568.
PMID: 35592248
PMC: 9110831.
DOI: 10.3389/fcell.2022.885568.
The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas.
Bragiel-Pieczonka A, Lipka G, Stapinska-Syniec A, Czyzewski M, Zybura-Broda K, Sobstyl M
Front Oncol. 2022; 12:621460.
PMID: 35494033
PMC: 9047681.
DOI: 10.3389/fonc.2022.621460.
Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.
Lopez-Bertoni H, Johnson A, Rui Y, Lal B, Sall S, Malloy M
Signal Transduct Target Ther. 2022; 7(1):37.
PMID: 35136034
PMC: 8826438.
DOI: 10.1038/s41392-021-00857-0.
5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer.
Wang K, Zhong W, Long Z, Guo Y, Zhong C, Yang T
Front Mol Biosci. 2021; 8:775304.
PMID: 34926580
PMC: 8672116.
DOI: 10.3389/fmolb.2021.775304.
Epigenetic Deregulation of the Histone Methyltransferase Contributes to Malignant Transformation in Glioblastoma.
Lopez V, Tejedor J, Carella A, Garcia M, Santamarina-Ojeda P, Perez R
Front Cell Dev Biol. 2021; 9:671838.
PMID: 34447744
PMC: 8383299.
DOI: 10.3389/fcell.2021.671838.
Targeting Immunometabolism in Glioblastoma.
Mohan A, Tomaszewski W, Haskell-Mendoza A, Hotchkiss K, Singh K, Reedy J
Front Oncol. 2021; 11:696402.
PMID: 34222022
PMC: 8242259.
DOI: 10.3389/fonc.2021.696402.
An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas.
Cai J, Zeng C, Hua W, Qi Z, Song Y, Lu X
Neurooncol Adv. 2021; 3(1):vdab049.
PMID: 34151267
PMC: 8209591.
DOI: 10.1093/noajnl/vdab049.
Parenteral high‑dose ascorbate - A possible approach for the treatment of glioblastoma (Review).
Renner O, Burkard M, Michels H, Vollbracht C, Sinnberg T, Venturelli S
Int J Oncol. 2021; 58(6).
PMID: 33955499
PMC: 8104923.
DOI: 10.3892/ijo.2021.5215.
The Role of 2-Oxoglutarate Dependent Dioxygenases in Gliomas and Glioblastomas: A Review of Epigenetic Reprogramming and Hypoxic Response.
Crake R, Burgess E, Royds J, Phillips E, Vissers M, Dachs G
Front Oncol. 2021; 11:619300.
PMID: 33842321
PMC: 8027507.
DOI: 10.3389/fonc.2021.619300.
The role of mA, mC and Ψ RNA modifications in cancer: Novel therapeutic opportunities.
Nombela P, Miguel-Lopez B, Blanco S
Mol Cancer. 2021; 20(1):18.
PMID: 33461542
PMC: 7812662.
DOI: 10.1186/s12943-020-01263-w.